HSBC Holdings’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $77K | Sell |
10,210
-7,363
| -42% | -$55.5K | ﹤0.01% | 2411 |
|
|
2025
Q1 | $94.8K | Buy |
17,573
+1,238
| +8% | +$6.68K | ﹤0.01% | 2359 |
|
|
2024
Q4 | $90.7K | Sell |
16,335
-200
| -1% | -$1.11K | ﹤0.01% | 2479 |
|
|
2024
Q3 | $166K | Sell |
16,535
-1,551
| -9% | -$15.6K | ﹤0.01% | 2306 |
|
|
2024
Q2 | $226K | Sell |
18,086
-2,303
| -11% | -$28.7K | ﹤0.01% | 2122 |
|
|
2024
Q1 | $356K | Sell |
20,389
-5,946
| -23% | -$104K | ﹤0.01% | 1920 |
|
|
2023
Q4 | $251K | Buy |
26,335
+15,949
| +154% | +$152K | ﹤0.01% | 1911 |
|
|
2023
Q3 | $115K | Buy |
+10,386
| New | +$115K | ﹤0.01% | 2035 |
|
|
2023
Q1 | – | Sell |
-7,144
| Closed | -$324K | – | 2299 |
|
|
2022
Q4 | $324K | Buy |
7,144
+1,402
| +24% | +$63.5K | ﹤0.01% | 2043 |
|
|
2022
Q3 | $302K | Sell |
5,742
-14,230
| -71% | -$748K | ﹤0.01% | 1990 |
|
|
2022
Q2 | $950K | Sell |
19,972
-352
| -2% | -$16.7K | ﹤0.01% | 1610 |
|
|
2022
Q1 | $1.47M | Buy |
20,324
+3,055
| +18% | +$221K | ﹤0.01% | 1460 |
|
|
2021
Q4 | $1.25M | Buy |
17,269
+5,365
| +45% | +$387K | ﹤0.01% | 1524 |
|
|
2021
Q3 | $681K | Sell |
11,904
-2
| -0% | -$114 | ﹤0.01% | 1659 |
|
|
2021
Q2 | $529K | Buy |
+11,906
| New | +$529K | ﹤0.01% | 1735 |
|
|
2021
Q1 | – | Sell |
-5,269
| Closed | -$218K | – | 2405 |
|
|
2020
Q4 | $218K | Buy |
5,269
+33
| +0.6% | +$1.37K | ﹤0.01% | 2320 |
|
|
2020
Q3 | $238K | Sell |
5,236
-15,059
| -74% | -$685K | ﹤0.01% | 1953 |
|
|
2020
Q2 | $1.02M | Buy |
+20,295
| New | +$1.02M | ﹤0.01% | 1131 |
|
|
2020
Q1 | – | Sell |
-14,740
| Closed | -$914K | – | 2288 |
|
|
2019
Q4 | $914K | Buy |
+14,740
| New | +$914K | ﹤0.01% | 1389 |
|